APTAMER THERAPEUTICS LIMITED

Company number 09059325 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

-£313,842

Balance sheet as at 2024-06-30

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2014-05-28
Employees
2 (2024 accounts)
Registered office
Windmill House, Innovation Way, York, England, YO10 5BR
Postcode
YO10 5BR
Capital
1 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2025-06-30
Next due by
2027-03-31
Financial year end
30 June

Confirmation statement

Last statement dated
2026-05-28
Next due by
2027-06-11
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 3 current · 3 resigned

Appointed 2023-08-21
Eleanor BROWN Director
Chief Financial Officer Appointed 2021-10-18
Appointed 2021-10-18

View all officers and resignations →

Group structure

Controlled by APTAMER GROUP PLC — since 2016-04-06

From persons-with-significant-control filings on the public register.

Contact details

Website
aptamertherapeutics.com

Custom antibody alternatives from Aptamer Group | High affinity & selectivity | Developed for research, diagnostics, bioprocessing and therapeutics.

Previous company names

NameDate changed
APTASORT LIMITED2019-05-25

Previous registered addresses 2

AddressChanged on
SUITE 2.78 - 2.91 BIO CENTRE INNOVATION WAY, HESLINGTON, YORK, NORTH YORKSHIRE, YO10 5NY, UNITED KINGDOM2020-12-16
SUITE 2.80 2.80 BIO CENTRE, INNOVATION WAY,, YORK, NORTH YORKSHIRE, YO10 5NY2018-11-01

Among its peers

Among the oldest 25%

of 32 similar companies in YO, trading since 2014

Competitors York

This company ranks 25 among research and experimental development on biotechnology in York.

Full league table →

The class of 2014

38%

of the 357 companies in this sector incorporated in 2014 are still active today; 59% have since been dissolved.

A fact about the year, not a forecast for this company.